Vivos Therapeutics increases at-the-market offering price for common stock
PositiveFinancial Markets

Vivos Therapeutics has announced an increase in the price of its at-the-market offering for common stock, signaling confidence in its financial strategy and market position. This move is significant as it reflects the company's growth potential and could attract more investors, ultimately supporting its mission to advance innovative therapies.
— Curated by the World Pulse Now AI Editorial System







